Found 14 matching trials
Delayed SLND for Patients With Breast Cancer Undergoing Primary Systemic Treatment N/A The goal of this study was to assess the feasibility of SLND by superparama...
Show More Status
Active Not Recruiting
Location
Uppsala University Hospital
Learn More & Join Trial
Selective Image Guided Resection of Pathologically Documented Axillary Lymph Node Metastases NA The purpose of this research study is to determine how feasible and accurat...
Show More Location
UNC- Chapel Hill Lineberger Comprehensive Cancer Center
Learn More & Join Trial
Validation of TAD in HER-2 with More Than 2 Lymph Nodes N/A The main objective of the study is to validate the DAT technique in patient...
Show More Status
Enrolling By Invitation
Location
Hospital Clínico de la Comunidad Valenciana
Learn More & Join Trial
Targeted Axillary Dissection After Neo-adjuvant Chemotherapy N/A Currently most breast cancer patients with confirmed axillary lymph node me...
Show More Location
Universitair Ziekenhuis Brussel
Learn More & Join Trial
TAD After Chemotherapy in Locally Advanced Breast Cancer N/A This is an observational study to validate target axillary dissection (TAD)...
Show More Location
Hospital de Bellvitge
Learn More & Join Trial
TAD in Primary Breast Cancer With Initially ≥ 3 Suspicious Lymph Nodes N/A Due to high pathological complete remission (pCR) rates in both breast and ...
Show More Location
Kliniken Essen-Mitte (KEM)
Learn More & Join Trial
Prospective Evaluation of Targeted Axillary Dissection (TAD) NA The purpose of this research is to evaluate how to manage the axillary lymp...
Show More Location
University of Miami
Learn More & Join Trial
Role of Axillary Lymph Node Dissection for Residual MACROMETASTASES After NEOADJUVANT Chemotherapy in Patients With HER2+ and Triple Negative Breast Cancer: The OPBC-11/MACRONAC Study N/A In this multicenter retrospective cohort study the aim is to determine the ...
Show More Location
Department Breast, Abdomen, Pelvis; Universitätsspital Basel
Learn More & Join Trial
Registry Trial to Evaluate the Clinical Utilization of Targeted Axillary Dissection (TAD) N/A A downstaging of axillary tumor-spread can be achieved in about 40% of the ...
Show More Location
Kliniken Essen-Mitte
Learn More & Join Trial
Targeted Axillary Dissection (TAD) in Early-stage Node Positive Breast Cancer NA RATIONALE: It is now standard for most breast cancer patients with 1-2 posi...
Show More Location
Hôpital Maisonneuve-Rosemont
Learn More & Join Trial